[1]
A. Velingker and D. Lawande, “Adverse drug reactions and treatment outcome analysis in multidrug resistant tuberculosis patients at a DOTS plus site”, Int J Basic Clin Pharmacol, vol. 9, no. 4, pp. 547–551, Mar. 2020.